561 related articles for article (PubMed ID: 7492129)
1. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
2. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group.
Drake LA; Fallon JD; Sober A
J Am Acad Dermatol; 1994 Oct; 31(4):613-6. PubMed ID: 8089287
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
5. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
6. Doxepin incorporated into a dermatologic cream: an assessment of both doxepin antipruritic action and doxepin action as an inhibitor of papules, in allergen and histamine-caused pruritus.
Greiding L; Moreno P
Allergol Immunopathol (Madr); 1999; 27(5):265-70. PubMed ID: 10568877
[TBL] [Abstract][Full Text] [Related]
7. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Boguniewicz M; Zeichner JA; Eichenfield LF; Hebert AA; Jarratt M; Lucky AW; Paller AS
J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
[TBL] [Abstract][Full Text] [Related]
8. Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial.
Kaufmann R; Bieber T; Helgesen AL; Andersen BL; Luger T; Poulin Y; Al-Hafidh J; Paul C;
Allergy; 2006 Mar; 61(3):375-81. PubMed ID: 16436149
[TBL] [Abstract][Full Text] [Related]
9. Doxepin toxicity in a child following topical administration.
Zell-Kanter M; Toerne TS; Spiegel K; Negrusz A
Ann Pharmacother; 2000 Mar; 34(3):328-9. PubMed ID: 10917379
[TBL] [Abstract][Full Text] [Related]
10. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience.
Taylor JS; Praditsuwan P; Handel D; Kuffner G
Arch Dermatol; 1996 May; 132(5):515-8. PubMed ID: 8624147
[TBL] [Abstract][Full Text] [Related]
11. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.
Groene D; Martus P; Heyer G
Exp Dermatol; 2001 Apr; 10(2):110-7. PubMed ID: 11260249
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
14. Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard.
Panahi Y; Davoudi SM; Beiraghdar F; Amiri M
Skinmed; 2011; 9(3):152-8. PubMed ID: 21675494
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
16. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
18. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
20. Doxepin cream for eczema?
Drug Ther Bull; 2000 Apr; 38(4):31-2. PubMed ID: 10845241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]